Class IITerminatedD-1328-2020
Drug recall · July 1, 2020
Sterile Cannabidiol recall
Why: Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sterile Cannabidiol (CBD) 50mg/mL, 10mL vial
- Lots / codes
Lot #: 101019P, 1010019P,10102019P, Exp. Date 10/10/2021
- Quantity
- N/A
- Company
- BIOTA Biosciences LLC, Seattle, WA
- Distribution
- Nationwide within the United States and New Zealand
- Initiated
- May 11, 2020 · Voluntary: Firm initiated
- Classified
- June 19, 2020
- Reported
- July 1, 2020
- Ended
- December 3, 2020
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedJul 1, 2020Sterile CannabidiolBIOTA Biosciences LLC · D-1326-2020Class IITerminatedJul 1, 2020Sterile CurcuminBIOTA Biosciences LLC · D-1327-2020Class IITerminatedJul 1, 2020Sterile CannabidiolBIOTA Biosciences LLC · D-1329-2020Class IITerminatedJul 1, 2020Sterile Curcumin 50mg/mLBIOTA Biosciences LLC · D-1330-2020
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.